Dare Bioscience Stock Forward View
| DARE Stock | USD 1.90 0.02 1.04% |
Dare Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Dare Bioscience stock prices and determine the direction of Dare Bioscience's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Dare Bioscience's historical fundamentals, such as revenue growth or operating cash flow patterns.
At the present time, the relative strength index (RSI) of Dare Bioscience's share price is approaching 46 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Dare Bioscience, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
EPS Estimate Next Quarter (0.40) | EPS Estimate Current Year (1.66) | EPS Estimate Next Year (0.35) | Wall Street Target Price 10.75 | EPS Estimate Current Quarter (0.39) |
Using Dare Bioscience hype-based prediction, you can estimate the value of Dare Bioscience from the perspective of Dare Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
Dare Relative Strength Index
The Naive Prediction forecasted value of Dare Bioscience on the next trading day is expected to be 2.09 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.42.Dare Bioscience Hype to Price Pattern
Investor biases related to Dare Bioscience's public news can be used to forecast risks associated with an investment in Dare. The trend in average sentiment can be used to explain how an investor holding Dare can time the market purely based on public headlines and social activities around Dare Bioscience. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Dare Bioscience's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Dare Bioscience.
The Naive Prediction forecasted value of Dare Bioscience on the next trading day is expected to be 2.09 with a mean absolute deviation of 0.09 and the sum of the absolute errors of 5.42. Dare Bioscience after-hype prediction price | USD 1.9 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Dare Bioscience to cross-verify your projections. Dare Bioscience Additional Predictive Modules
Most predictive techniques to examine Dare price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dare using various technical indicators. When you analyze Dare charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Dare Bioscience Cash Forecast
Forecasting cash, or other financial indicators, requires analysts to apply different statistical methods, techniques, and algorithms to find hidden patterns within the Dare Bioscience's financial statements to predict how it will affect future prices.
Cash | First Reported 2013-12-31 | Previous Quarter 5 M | Current Value 23.1 M | Quarterly Volatility 23.2 M |
Dare Bioscience Naive Prediction Price Forecast For the 31st of January
Given 90 days horizon, the Naive Prediction forecasted value of Dare Bioscience on the next trading day is expected to be 2.09 with a mean absolute deviation of 0.09, mean absolute percentage error of 0.01, and the sum of the absolute errors of 5.42.Please note that although there have been many attempts to predict Dare Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Dare Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Dare Bioscience Stock Forecast Pattern
| Backtest Dare Bioscience | Dare Bioscience Price Prediction | Buy or Sell Advice |
Dare Bioscience Forecasted Value
In the context of forecasting Dare Bioscience's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Dare Bioscience's downside and upside margins for the forecasting period are 0.02 and 6.44, respectively. We have considered Dare Bioscience's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Dare Bioscience stock data series using in forecasting. Note that when a statistical model is used to represent Dare Bioscience stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 115.6505 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0874 |
| MAPE | Mean absolute percentage error | 0.0442 |
| SAE | Sum of the absolute errors | 5.4193 |
Predictive Modules for Dare Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Dare Bioscience. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Dare Bioscience After-Hype Price Density Analysis
As far as predicting the price of Dare Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Dare Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Dare Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Dare Bioscience Estimiated After-Hype Price Volatility
In the context of predicting Dare Bioscience's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Dare Bioscience's historical news coverage. Dare Bioscience's after-hype downside and upside margins for the prediction period are 0.10 and 6.22, respectively. We have considered Dare Bioscience's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Dare Bioscience is dangerous at this time. Analysis and calculation of next after-hype price of Dare Bioscience is based on 3 months time horizon.
Dare Bioscience Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Dare Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Dare Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Dare Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.07 | 4.35 | 0.01 | 0.01 | 10 Events / Month | 7 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
1.90 | 1.90 | 0.00 |
|
Dare Bioscience Hype Timeline
Dare Bioscience is currently traded for 1.90. The entity has historical hype elasticity of -0.01, and average elasticity to hype of competition of -0.01. Dare is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is over 100%. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.07%. %. The volatility of related hype on Dare Bioscience is about 4306.93%, with the expected price after the next announcement by competition of 1.89. The company recorded a loss per share of 1.83. Dare Bioscience last dividend was issued on the 20th of July 2017. The entity had 1:12 split on the 1st of July 2024. Given the investment horizon of 90 days the next projected press release will be in about 10 days. Check out Historical Fundamental Analysis of Dare Bioscience to cross-verify your projections.Dare Bioscience Related Hype Analysis
Having access to credible news sources related to Dare Bioscience's direct competition is more important than ever and may enhance your ability to predict Dare Bioscience's future price movements. Getting to know how Dare Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Dare Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| FBLG | FibroBiologics Common Stock | 0.04 | 19 per month | 8.24 | (0) | 14.71 | (12.82) | 47.13 | |
| CTXR | Citius Pharmaceuticals | (0.03) | 1 per month | 0.00 | (0.18) | 10.59 | (10.53) | 38.23 | |
| LPTX | LPTX Old | 0.10 | 22 per month | 6.90 | 0.14 | 25.00 | (9.43) | 65.13 | |
| AIMD | Ainos Inc | (0.07) | 8 per month | 0.00 | (0.09) | 11.43 | (9.79) | 28.00 | |
| ATHA | Athira Pharma | (0.54) | 8 per month | 3.40 | 0.11 | 7.83 | (6.40) | 70.38 | |
| ASBP | Aspire BioPharma | (0.55) | 6 per month | 0.00 | (0.24) | 19.52 | (23.85) | 63.79 | |
| ADTX | Aditxt Inc | (0.06) | 10 per month | 0.00 | (0.27) | 22.54 | (27.59) | 63.67 | |
| PALI | Palisade Bio | (0.03) | 4 per month | 6.61 | 0.01 | 13.86 | (10.26) | 31.35 | |
| ANL | Adlai Nortye Ltd | 0.22 | 6 per month | 5.83 | 0.17 | 15.22 | (11.76) | 42.22 | |
| HOTH | Hoth Therapeutics | (0.09) | 20 per month | 0.00 | (0.18) | 4.81 | (5.79) | 14.85 |
Other Forecasting Options for Dare Bioscience
For every potential investor in Dare, whether a beginner or expert, Dare Bioscience's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dare Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dare. Basic forecasting techniques help filter out the noise by identifying Dare Bioscience's price trends.Dare Bioscience Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dare Bioscience stock to make a market-neutral strategy. Peer analysis of Dare Bioscience could also be used in its relative valuation, which is a method of valuing Dare Bioscience by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dare Bioscience Market Strength Events
Market strength indicators help investors to evaluate how Dare Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dare Bioscience shares will generate the highest return on investment. By undertsting and applying Dare Bioscience stock market strength indicators, traders can identify Dare Bioscience entry and exit signals to maximize returns.
Dare Bioscience Risk Indicators
The analysis of Dare Bioscience's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dare Bioscience's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dare stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.04 | |||
| Standard Deviation | 4.22 | |||
| Variance | 17.81 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dare Bioscience
The number of cover stories for Dare Bioscience depends on current market conditions and Dare Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dare Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dare Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Dare Bioscience Short Properties
Dare Bioscience's future price predictability will typically decrease when Dare Bioscience's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dare Bioscience often depends not only on the future outlook of the potential Dare Bioscience's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dare Bioscience's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 8.5 M | |
| Cash And Short Term Investments | 15.7 M |
Check out Historical Fundamental Analysis of Dare Bioscience to cross-verify your projections. For information on how to trade Dare Stock refer to our How to Trade Dare Stock guide.You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Will Health Care Equipment & Supplies sector continue expanding? Could Dare diversify its offerings? Factors like these will boost the valuation of Dare Bioscience. Projected growth potential of Dare fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Dare Bioscience data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.83) | Revenue Per Share | Quarterly Revenue Growth (0.95) | Return On Assets | Return On Equity |
Understanding Dare Bioscience requires distinguishing between market price and book value, where the latter reflects Dare's accounting equity. The concept of intrinsic value—what Dare Bioscience's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Dare Bioscience's price substantially above or below its fundamental value.
It's important to distinguish between Dare Bioscience's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dare Bioscience should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. In contrast, Dare Bioscience's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.